Assets can be established or in development and include but are not limited to -- core technologies & products, services, and capabilities such R&D and channels.
The following are examples of how Vaxa has assisted companies to Commerialize IP for other uses::
- Alternate applications for materials used in diapers.
- Using semiconductor chip technologies in digital displays.
- Combining assets in food, chemicals, & pharmaceuticals to serve the nutriceuticals market.
- Leveraging manufacturing data management applications into financial services.
- Using plastics technologies for woundcare products.
The above are just some ways in which Vaxa has assisted clients from a range of industries who want to take existing technological assets or competencies and finding adjacent market revenue opportunities.
Viable monetization go-to-market options depend on the strategic nature of the assets being considered. We take a hybrid approach so that all internal and external options are explored.
Our IP Commercialization research deliverables include but are not limited to:
- A portfolio of alternate applications for named technologies.
- Customer value proposition.
- Competitor analysis.
- Addressable market and scenario analysis of future revenues.
To find out more about how Vaxa has helped clients in this area, please contact us at frontend@vaxainc.com. |
